Skip to content

Hybrid Assistive Limb Effect on Jump Height: a Clinical Study

Hybrid Assistive Limb Effect on Jump Height: a Clinical Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06695728
Enrollment
30
Registered
2024-11-19
Start date
2024-11-19
Completion date
2025-02-23
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sport Injury

Brief summary

The aim of this study is to investigate the effect of exercises performed with The Hybrid Assistive Limb device on the jump height of healthy non-athlete individuals.

Detailed description

Cyberdyne Waist Type device will be worn by attaching 3 electrodes to the waist area and then attaching the device to the waist and legs with the help of belts. Then, the appropriate modes will be selected for the participant with the adjustments made on the device. It has 3 modes; CVC, the mode that produces torque value, that is, movement, according to muscle activation with only the bioelectric signals received from the person's skin. CAC, the mode that produces movement by presenting automatic values to the participant with data designed according to the specific software and algorithm of the device. CIC, the mode that produces movement completely according to the participant's control. In our study, investigators will produce movement according to the muscle activation created by the participant using the CVC mode. In this way, investigators will provide the brain-muscle relationship and motor learning parameters. The exercises will be applied for 30 minutes, 5 days a week, for a total of 40 sessions.

Interventions

OTHERexercise

It consists of exercises to be done with the exoskeleton. These are; jumping exercise, squat, sit-stand and forward bending exercises.

Sponsors

Uskudar University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Being between 20 and 40 years old. * Tall individuals over 120 cm (for accurate visual feedback in the assessment of jump height) * Weighting less than 100 kg * People who can perceive and follow the given instructions without any problems * People who have not had any surgery in the last 6 months * People who are not allergic to electrodes * They should not have any skin tissue related disorders. * People who do not use pacemakers * People who do not have a history of seizures or a risk of seizures (epilepsy). * They should not have heart and respiratory problems. * People who have not experienced back pain in the last 3 months. * People whose waist circumference is not more than 120 cm and whose thigh circumference is not more than 80 cm. * No orthopedic or neurological problems that will affect the balance mechanism (e.g. Vertigo, cerebellum damage, ataxia). * Not having used a Waist Type Hybrid Assistive Limb device before * Not having worked with visual feedback devices such as Tecnobody D-Wall before * Not having worked with any of the Cyberdyne Hybrid Assistive Limb devices before

Exclusion criteria

* People with back pain or who have had surgery on their back * Having had surgery within the last 6 months.

Design outcomes

Primary

MeasureTime frameDescription
D-Wall (TecnoBody SRL, Italy)8 weeksD-Wall (TecnoBody SRL, Italy) is a digital mirror device consisting of a powerful platform paired with a control computer and a high-resolution 3D Kinect camera equipped with infrared beams that allow for motion capture. The system provides instant feedback on the patient's movements on a large LCD monitor, offering VR-based mirror therapy and game-based exercises.This device measures the jump height and the amount of power consumed. It records the data and presents the result numerically.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026